Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population

NCT07382076 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-02-02

No results posted yet for this study

Summary

Measuring Activated Clotting Time (ACT) using the i-STAT ACTpro cartridge on the i-STAT 1 analyzer compared to a comparator device.

Conditions

  • Activated Clotting Time

Interventions

DIAGNOSTIC_TEST

Blood draw

A total volume of no more than 5mL of blood will be prospectively collected from subjects.

Sponsors & Collaborators

  • Abbott Point of Care

    lead INDUSTRY

Principal Investigators

  • Manish Gupta, MS, MBA · Abbott Point of Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2026-03-30
Completion
2026-03-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07382076 on ClinicalTrials.gov